1-(2,6-Dichlorophenyl)-2-indolinone

Catalog No.: 
ACJTBZ139
CAS No.: 
15362-40-0
Molecular Formula: 
C14H9Cl2NO
Molecular Weight: 
278.14
1-(2,6-Dichlorophenyl)-2-indolinone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
500g97%$98.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(2,6-Dichlorophenyl)-2-indolinone
IUPAC Name1-(2,6-dichlorophenyl)indolin-2-one
MDL No.MFCD00451393
Molecular FormulaC14H9Cl2NO
Molecular Weight278.14
SMILESC1=CC=CC2=C1N(C(C2)=O)C3=C(Cl)C=CC=C3Cl
InChI KeyJCICIFOYVSPMHG-UHFFFAOYSA-N
Synonym1-(2,6-Dichlorophenyl)-1,3-dihydro-2H-indol-2-one | 1-(2,6-Dichloro-phenyl)-1,3-dihydro-indol-2-one | A809449 | Diclofenac impurity A, European Pharmacopoeia (EP) Reference Standard | NCGC00245217-01 | 1-(2,6-dichlorophenyl)-2,3-dihydro-1H-indol-2-one | D
CAS No.15362-40-0
PubChem CID27211

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACJTBZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACGHQX956 route compound structure diagram
    ACGHQX956119623-66-4In Stock
  2. Then
  3. ACJTBZ139 route product structure diagram
    ACJTBZ13915362-40-0
Inquiry

2. ACJTBZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACACMZ105 route compound structure diagram
    ACACMZ10519230-28-5In Stock
  2. Plus
  3. ACSIOZ962 route compound structure diagram
    ACSIOZ96259-48-3In Stock
  4. Then
  5. ACJTBZ139 route product structure diagram
    ACJTBZ13915362-40-0
Inquiry

3. ACJTBZ139 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJTBZ139 route product structure diagram
    ACJTBZ13915362-40-0
Inquiry

Comments (0)